Tokyo, Japan

Hideharu Anazawa

This inventor holds 29 USPTO granted patents and 2 published patent applications and 8 EPO patents, primarily in Immunotherapy Development. Top assignees: Kyowa Hakko Kogyo Co., Ltd., Kyowa Hakko Kirin Co., Limited, Shin Nihon Chemical Co., Ltd.. Active years: 1988-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideharu Anazawa. Retrieved from https://idiyas.com/inventor/hideharu-anazawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 29 

% Patents Active = 55.2

 

Average Co-Inventor Count = 6.9

ph-index = 14

Forward Citations = 517(Granted Patents)


Location History:

  • Nerima-ku, JP (2007)
  • Tokyo, JP (1988 - 2010)
  • Chiyoda-ku, JP (2014 - 2019)

Company Filing History:


Years Active: 1988-2019

Loading Chart...
Loading Chart...
Areas of Expertise:
Immunotherapy
Antibody Compositions
Functional Immune Molecules
Interleukin-5
Platelet-Derived Growth Factor
CXCR4 Protein
Her-2
ADCC
Phytase
Anemia Treatment
Steroid Sulfatase Inhibitors
Monoclonal Antibodies
29 patents (USPTO):Explore Patents

Title: Innovations by Hideharu Anazawa: A Pioneer in Immunology

Introduction

Hideharu Anazawa, based in Tokyo, Japan, is an accomplished inventor with a remarkable portfolio of 29 patents. His work predominantly focuses on the field of immunology, developing innovative methods that enhance the activities of immune molecules. Anazawa's contributions have the potential to significantly impact therapeutic approaches in various medical conditions.

Latest Patents

Among Anazawa's latest innovations is a groundbreaking patent concerning a method of modulating the activity of functional immune molecules. This invention provides a new way to control the functionality of immunologically active molecules such as antibodies, proteins, and peptides. It describes an agent capable of promoting the activity of these immune molecules and outlines immunologically functional molecules that exhibit improved activity due to this modulation. This invention reflects Anazawa's commitment to advancing the field of immunology through scientific innovation.

Career Highlights

Throughout his career, Hideharu Anazawa has made significant contributions to the pharmaceutical industry while working at notable companies such as Kyowa Hakko Kogyo Co., Ltd. and Kyowa Hakko Kirin Co., Limited. His experience in these leading organizations has enabled him to refine his expertise in the development and implementation of novel therapeutic methods.

Collaborations

Anazawa has collaborated with talented professionals in his field, including Nobuo Hanai and Kazuyasu Nakamura. These collaborations have facilitated the exchange of ideas and fostered innovative approaches to the challenges present in immunological research.

Conclusion

Hideharu Anazawa's impressive array of patents demonstrates his innovative spirit and dedication to enhancing our understanding of immune functions. His work has the potential to revolutionize treatments in immunology, making him a significant figure in the field of medical science. As he continues to develop new methods and collaborate with other experts, Anazawa's contributions will undoubtedly shape the future of immunological therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…